Literature DB >> 23906799

Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication.

Timothy P Murphy1, Matthew R Reynolds, David J Cohen, Judith G Regensteiner, Joseph M Massaro, Donald E Cutlip, Emile R Mohler, Joselyn Cerezo, Niki C Oldenburg, Claudia C Thum, Suzanne Goldberg, Alan T Hirsch.   

Abstract

PURPOSE: To examine the relationship between objective treadmill test outcomes and subjective symptom outcomes among patients with claudication treated with stent revascularization (ST) compared with supervised exercise (SE).
MATERIALS AND METHODS: Five scales of the Peripheral Artery Questionnaire and Walking Impairment Questionnaire were correlated with peak walking time and treadmill claudication onset time.
RESULTS: The correlation between change in disease-specific quality of life (QOL) and change in peak walking time differed according to treatment group, with statistically significant correlations for all five scales for the ST group and weaker trends for the SE group, only one of which was statistically significant. In contrast, improvements in disease-specific QOL correlated well with increases in claudication onset time, with no significant interaction with treatment group for any of the five scales.
CONCLUSIONS: Disease-specific QOL results at 6 months in the Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study show that improved maximal treadmill walking in patients with claudication treated with SE correlated poorly with self-reported symptom relief. Conversely, patients treated with ST showed good correlation between improved maximal treadmill walking and self-reported symptom improvement. The correlation between claudication onset time and self-reported symptom relief was good across treatment groups. This finding indicates that traditional objective treadmill test outcomes may not correlate well with symptom relief in patients with claudication. Future studies should investigate these data and improve understanding of patient relevance of traditional objective treadmill-based treatment outcomes. © SIR, 2013.

Entities:  

Keywords:  CLEVER; COT; Claudication: Exercise Vs. Endoluminal Revascularization; OMC; PAD; PAQ; PWT; Peripheral Artery Questionnaire; QOL; SE; ST; WIQ; Walking Impairment Questionnaire; claudication onset time; optimal medical care; peak walking time; peripheral artery disease; quality of life; stent revascularization; supervised exercise

Mesh:

Year:  2013        PMID: 23906799      PMCID: PMC4724411          DOI: 10.1016/j.jvir.2013.05.057

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  25 in total

1.  Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training--randomized controlled trial.

Authors:  Sandra Spronk; Johanna L Bosch; Pieter T den Hoed; Hermanus F Veen; Peter M T Pattynama; M G Myriam Hunink
Journal:  Radiology       Date:  2009-02       Impact factor: 11.105

2.  Reliability of treadmill testing in peripheral arterial disease: a meta-regression analysis.

Authors:  Saskia P A Nicolaï; Wolfgang Viechtbauer; Lotte M Kruidenier; Math J J M Candel; Martin H Prins; Joep A W Teijink
Journal:  J Vasc Surg       Date:  2009-08       Impact factor: 4.268

3.  Walking performance and health-related quality of life after surgical or endovascular invasive versus non-invasive treatment for intermittent claudication--a prospective randomised trial.

Authors:  J Nordanstig; J Gelin; M Hensäter; C Taft; K Österberg; L Jivegård
Journal:  Eur J Vasc Endovasc Surg       Date:  2011-03-11       Impact factor: 7.069

4.  Quality of life and exercise performance after aortoiliac stent placement for claudication.

Authors:  Timothy P Murphy; Gregory M Soares; H Myra Kim; Sun H Ahn; Richard A Haas
Journal:  J Vasc Interv Radiol       Date:  2005-07       Impact factor: 3.464

5.  Quantifying improvement in symptoms, functioning, and quality of life after peripheral endovascular revascularization.

Authors:  David M Safley; John A House; Steven B Laster; William C Daniel; John A Spertus; Steven P Marso
Journal:  Circulation       Date:  2007-01-22       Impact factor: 29.690

Review 6.  Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.

Authors:  W R Hiatt; A T Hirsch; J G Regensteiner; E P Brass
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

7.  Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States.

Authors:  Elizabeth M Mahoney; Kaijun Wang; Hong H Keo; Sue Duval; Kim G Smolderen; David J Cohen; Gabriel Steg; Deepak L Bhatt; Alan T Hirsch
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-10-12

8.  The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods.

Authors:  Timothy P Murphy; Alan T Hirsch; John J Ricotta; Donald E Cutlip; Emile Mohler; Judith G Regensteiner; Anthony J Comerota; David J Cohen
Journal:  J Vasc Surg       Date:  2008-04-25       Impact factor: 4.268

9.  Exercise training improves functional status in patients with peripheral arterial disease.

Authors:  J G Regensteiner; J F Steiner; W R Hiatt
Journal:  J Vasc Surg       Date:  1996-01       Impact factor: 4.268

10.  Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study.

Authors:  Ulf G Bronas; Alan T Hirsch; Timothy Murphy; Dalynn Badenhop; Tracie C Collins; Jonathan K Ehrman; Abby G Ershow; Beth Lewis; Diane J Treat-Jacobson; M Eileen Walsh; Niki Oldenburg; Judith G Regensteiner
Journal:  Vasc Med       Date:  2009-11       Impact factor: 3.239

View more
  6 in total

Review 1.  Treating femoropopliteal disease: established and emerging technologies.

Authors:  Athanasios Diamantopoulos; Konstantinos Katsanos
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

Review 2.  Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia.

Authors:  Mary McGrae McDermott
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

3.  Community walking speed, sedentary or lying down time, and mortality in peripheral artery disease.

Authors:  Mary M McDermott; Jack M Guralnik; Luigi Ferrucci; Lu Tian; Melina R Kibbe; Philip Greenland; David Green; Kiang Liu; Lihui Zhao; John T Wilkins; Mark D Huffman; Sanjiv J Shah; Yihua Liao; Ying Gao; Donald M Lloyd-Jones; Michael H Criqui
Journal:  Vasc Med       Date:  2016-02-12       Impact factor: 3.239

4.  Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial.

Authors:  Matthew R Reynolds; Patricia Apruzzese; Benjamin Z Galper; Timothy P Murphy; Alan T Hirsch; Donald E Cutlip; Emile R Mohler; Judith G Regensteiner; David J Cohen
Journal:  J Am Heart Assoc       Date:  2014-11-11       Impact factor: 5.501

5.  Is the relationship among outcome variables shown in randomized trials?

Authors:  David L Schriger; Richelle J Cooper; Ana Lopez-O'Sullivan; Carter Wystrach; Douglas G Altman
Journal:  Trials       Date:  2015-02-22       Impact factor: 2.279

6.  Correlation between Patient-Reported Symptoms and Ankle-Brachial Index after Revascularization for Peripheral Arterial Disease.

Authors:  Hyung Gon Je; Bo Hyun Kim; Kyoung Im Cho; Jae Sik Jang; Yong Hyun Park; John Spertus
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.